TheraRadar
← All Targets

Amyloid beta plaques

1 drugs
CNS
1
Approved Drugs
1
Companies
2
Indications
1
Therapeutic Areas
Broadest Approval
AMYVID
AVID RADIOPHARMS INC
2
approved indications

Drug Modality Landscape

Modalities

Small molecule
1
100%

Routes of Administration

💉 IV
1
100%
💡

Only one approved drug targets Amyloid beta plaques, using small molecule modality.

Small molecules only

Pro Intelligence Preview

Deep insights for drug target analysis

Competitive Landscape

  • 1 companies competing
  • Market share by company

Full Drug Portfolio

  • All 1 approved drugs
  • Approval dates & indications

Genetic Validation

  • Full genetic evidence table
  • Effect sizes & directions

Approval Timeline

  • Full 1-drug timeline
  • First-of-modality markers
Unlock Full Intelligence

Full summary • All drugs • Genetic evidence • Trials • Timeline